Search for authorsSearch for similar articles
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Small molecule-mediated rapid maturation of human induced pluripotent stem cell-derived cardiomyocytes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (iPSC-CMs) do not display all hallmarks of mature primary cardiomyocytes, especially the ability to use fatty acids (FA) as an energy source, containing high mitochondrial mass, presenting binucleation and increased DNA content per nuclei (polyploidism), and synchronized electrical conduction. This immaturity represents a bottleneck to their application in (1) disease modelling—as most cardiac (genetic) diseases have a middle-age onset—and (2) clinically relevant models, where integration and functional coupling are key. So far, several methods have been reported to enhance iPSC-CM maturation; however, these protocols are laborious, costly, and not easily scalable. Therefore, we developed a simple, low-cost, and rapid protocol to promote cardiomyocyte maturation using two small molecule activators of the peroxisome proliferator-activated receptor β/δ and gamma coactivator 1-alpha (PPAR/PGC-1α) pathway: asiatic acid (AA) and GW501516 (GW).

          Methods and Results

          Monolayers of iPSC-CMs were incubated with AA or GW every other day for ten days resulting in increased expression of FA metabolism-related genes and markers for mitochondrial activity. AA-treated iPSC-CMs responsiveness to the mitochondrial respiratory chain inhibitors increased and exhibited higher flexibility in substrate utilization. Additionally, structural maturity improved after treatment as demonstrated by an increase in mRNA expression of sarcomeric-related genes and higher nuclear polyploidy in AA-treated samples. Furthermore, treatment led to increased ion channel gene expression and protein levels.

          Conclusions

          Collectively, we developed a fast, easy, and economical method to induce iPSC-CMs maturation via PPAR/PGC-1α activation. Treatment with AA or GW led to increased metabolic, structural, functional, and electrophysiological maturation, evaluated using a multiparametric quality assessment.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s13287-022-03209-z.

          Related collections

          Most cited references89

          • Record: found
          • Abstract: found
          • Article: not found

          Evidence for cardiomyocyte renewal in humans.

          It has been difficult to establish whether we are limited to the heart muscle cells we are born with or if cardiomyocytes are generated also later in life. We have taken advantage of the integration of carbon-14, generated by nuclear bomb tests during the Cold War, into DNA to establish the age of cardiomyocytes in humans. We report that cardiomyocytes renew, with a gradual decrease from 1% turning over annually at the age of 25 to 0.45% at the age of 75. Fewer than 50% of cardiomyocytes are exchanged during a normal life span. The capacity to generate cardiomyocytes in the adult human heart suggests that it may be rational to work toward the development of therapeutic strategies aimed at stimulating this process in cardiac pathologies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Dynamics of Cell Generation and Turnover in the Human Heart.

            The contribution of cell generation to physiological heart growth and maintenance in humans has been difficult to establish and has remained controversial. We report that the full complement of cardiomyocytes is established perinataly and remains stable over the human lifespan, whereas the numbers of both endothelial and mesenchymal cells increase substantially from birth to early adulthood. Analysis of the integration of nuclear bomb test-derived (14)C revealed a high turnover rate of endothelial cells throughout life (>15% per year) and more limited renewal of mesenchymal cells (<4% per year in adulthood). Cardiomyocyte exchange is highest in early childhood and decreases gradually throughout life to <1% per year in adulthood, with similar turnover rates in the major subdivisions of the myocardium. We provide an integrated model of cell generation and turnover in the human heart.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cardiomyocyte proliferation contributes to heart growth in young humans.

              The human heart is believed to grow by enlargement but not proliferation of cardiomyocytes (heart muscle cells) during postnatal development. However, recent studies have shown that cardiomyocyte proliferation is a mechanism of cardiac growth and regeneration in animals. Combined with evidence for cardiomyocyte turnover in adult humans, this suggests that cardiomyocyte proliferation may play an unrecognized role during the period of developmental heart growth between birth and adolescence. We tested this hypothesis by examining the cellular growth mechanisms of the left ventricle on a set of healthy hearts from humans aged 0-59 y (n = 36). The percentages of cardiomyocytes in mitosis and cytokinesis were highest in infants, decreasing to low levels by 20 y. Although cardiomyocyte mitosis was detectable throughout life, cardiomyocyte cytokinesis was not evident after 20 y. Between the first year and 20 y of life, the number of cardiomyocytes in the left ventricle increased 3.4-fold, which was consistent with our predictions based on measured cardiomyocyte cell cycle activity. Our findings show that cardiomyocyte proliferation contributes to developmental heart growth in young humans. This suggests that children and adolescents may be able to regenerate myocardium, that abnormal cardiomyocyte proliferation may be involved in myocardial diseases that affect this population, and that these diseases might be treatable through stimulation of cardiomyocyte proliferation.
                Bookmark

                Author and article information

                Contributors
                A.vanMil@umcutrecht.nl
                Journal
                Stem Cell Res Ther
                Stem Cell Res Ther
                Stem Cell Research & Therapy
                BioMed Central (London )
                1757-6512
                27 December 2022
                27 December 2022
                2022
                : 13
                : 531
                Affiliations
                [1 ]GRID grid.5477.1, ISNI 0000000120346234, Circulatory Health Laboratory, Regenerative Medicine Center Utrecht, , University Utrecht, University Medical Center Utrecht, ; Utrecht, The Netherlands
                [2 ]GRID grid.7692.a, ISNI 0000000090126352, Laboratory of Experimental Cardiology, Department of Cardiology, , University Medical Center Utrecht, ; Utrecht, The Netherlands
                [3 ]GRID grid.6190.e, ISNI 0000 0000 8580 3777, Center for Physiology and Pathophysiology, Institute for Neurophysiology, Faculty of Medicine and University Hospital Cologne, , University of Cologne, ; Cologne, Germany
                [4 ]GRID grid.491096.3, Department of Cardiology, , Amsterdam Medical Centre, ; 1105 AZ Amsterdam, The Netherlands
                [5 ]GRID grid.411737.7, Netherlands Heart Institute, ; Utrecht, The Netherlands
                Author information
                http://orcid.org/0000-0002-3787-6466
                Article
                3209
                10.1186/s13287-022-03209-z
                9795728
                36575473
                9836876f-5a3a-4b3c-87fc-6a9240037e71
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 15 August 2022
                : 1 December 2022
                Funding
                Funded by: Gravitation Program “Materials Driven Regeneration” by the Netherlands Organization for Scientific Research (RegmedXB)
                Award ID: 024.003.013
                Award Recipient :
                Funded by: Marie Skłodowska-Curie Actions RESCUE
                Award ID: 801540
                Award Recipient :
                Funded by: PLN Foundation
                Funded by: HARVEY
                Award ID: 18747 NWO otp
                Award Recipient :
                Funded by: EU-funded project BRAV3 (H2020)
                Award ID: 874827
                Award ID: 874827
                Award Recipient :
                Funded by: European Research Council (ERC) under the EVICARE grant
                Award ID: 725229
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2022

                Molecular medicine
                human induced pluripotent stem cell-derived cardiomyocyte,maturation,asiatic acid,gw501516,pgc-1α,ppar

                Comments

                Comment on this article